Coenzyme Q10: It's Everywhere
Download in electronic PDF format for $75
Abstract: A considerable body of experimental evidence suggests that the nutrient Coenzyme Q10 may be helpful as an adjunct to conventional medical therapy in treating a wide variety of disorders. This article features Coenzyme Q10, focusing on its historical use, description, mechanism of action, the current state of knowledge, testimonials and its growing market. Sidebars provide a listing of conditions for which experimental evidence suggests Coenzyme Q10 may be helpful, a listing of milestones in the development of Coenzyme Q10, a formulation (Ubidicarenone [Coenzyme Q10] 200-mg Gelatin Troche) and a brief listing of studies with Coenzyme Q10 for periodontal disease. Comments are included by compounding pharmacists who are already working with this nutrient.
Related Keywords:
ubiquinone, Hmg-coa, Reductase
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Coenzyme Q10: It's Everywhere
Hudson Sonora
|
Jan/Feb 1999
Pg. 30-33
|
Carnitine 400-mg/mL and Coenzyme Q10 10-mg/mL Solution
Allen Loyd V Jr
|
Sep/Oct 2008
Pg. 448
|
Coenzyme Q10 Supplementation in the Treatment of Heart Disease
Bramwell Bethany L
|
Mar/Apr 2010
Pg. 108-111
|
Ubidicarenone (Coenzyme Q10) 200-mg Gelatin Troche
Roentsch George
|
Jan/Feb 1999
Pg. 32
|
Coenzyme Q10 200-mg Chewable Troches
Allen Loyd V Jr
|
Mar/Apr 2000
Pg. 129
|
Coenzyme Q10 100-mg-in-Oil Capsules
Glasnapp Andrew
|
Jul/Aug 2003
Pg. 291
|
Basics of Compounding for Raynaud's Disease
Glasnapp Andrew
|
Jul/Aug 2003
Pg. 288-291
|
PostScription: Experts Everywhere
Rahe Hank
|
Mar/Apr 2005
Pg. 167
|
Hormone Therapy: It's Time for a Second Opinion
Collins Joseph J, Ahlgrimm Maria
|
Mar/Apr 2008
Pg. 122-127
|
Finally: A Final U.S. Food and Drug Administration Memorandum of Understanding, but It's Flawed
Brunner Scott
|
Jul/Aug 2020
Pg. 296-297
|
It's Time for a New Philosophy
Brunner Scott
|
Sep/Oct 2021
Pg. 386-387
|
Minimizing the Risk of Cholesterol-Lowering Therapy
Pratt Sam
|
Sep/Oct 2001
Pg. 362-364
|
Clinical Efficacy of a Topical Compounded Formulation in Male Androgenetic Alopecia: Minoxidil 10%, Finasteride 0.1%, Biotin 0.2%, and Caffeine Citrate 0.05% Hydroalcoholic Solution
Marotta James C, Patel Gopesh, Carvalho Maria, Blakeney Samantha
|
Jan/Feb 2020
Pg. 69-76
|
Compounded Testosterone Troches to optimize Health and the Testosterone Controversy
Guth Michael AS
|
May/Jun 2015
Pg. 195-203
|
Hormonal Influences in Prostate Cancer: An Update of a Complex Subject
Biundo Bruce
|
Mar/Apr 2010
Pg. 100-104
|
Burning Mouth Syndrome: A Discussion of a Complex Pathology
Zur Eyal
|
May/Jun 2012
Pg. 196-205
|
Documentation: Records and Reports
Akers Michael J
|
Sep/Oct 2017
Pg. 373-380
|
Green IV Nutritionals
Karolchyk Scott
|
Jul/Aug 1999
Pg. 260-261
|
Nicotinamide-Adenine Dinucleotide (NADH) in Parkinson's Disease and Alzheimer's Disease
Glasnapp Andrew, Schaefer Erin
|
Jul/Aug 2000
Pg. 276-279
|
Intravenous Admixture Preparation Considerations, Part 7: Stability Issues
Allen Loyd V Jr
|
Nov/Dec 2020
Pg. 473-478
|
Return to Top |